No Data
Cisen Pharmaceutical (603367.SH) will distribute 0.22 yuan per share for the half-year, with the equity registration date on November 21.
Cisen Pharmaceutical (603367.SH) announced that the company will implement the 2024 semi-annual equity distribution, distributing per share...
Solid Earnings May Not Tell The Whole Story For Cisen Pharmaceutical (SHSE:603367)
Chenxin Pharmaceutical: Report of Chenxin Pharmaceutical Co., Ltd. for the third quarter of 2024
Chenxin Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Cisen Pharmaceutical (603367.SH): The net income for the first three quarters was 0.398 billion yuan, an increase of 1.97% year-on-year.
Great Wisdom October 28th | Cisen Pharmaceutical (603367.SH) released the third quarter report, with revenue of 3 billion yuan in the first three quarters, a 6.47% year-on-year decrease, net income of 0.398 billion yuan, an increase of 1.97% year-on-year, non-net income of 0.363 billion yuan, a 2.49% year-on-year decrease, and basic earnings per share of 0.88 yuan.
Private Companies Are Cisen Pharmaceutical Co., Ltd.'s (SHSE:603367) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥398m Last Week
